Roche Holding AG (RHHBF)
Roche Market Cap : 381.98B for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 381.98B |
| November 16, 2026 | 402.41B |
| November 13, 2026 | 382.42B |
| November 12, 2026 | 395.94B |
| November 11, 2026 | 382.22B |
| November 10, 2026 | 382.22B |
| November 09, 2026 | 394.40B |
| November 06, 2026 | 389.20B |
| November 05, 2026 | 391.61B |
| November 04, 2026 | 391.61B |
| November 03, 2026 | 390.42B |
| November 02, 2026 | 391.31B |
| October 30, 2026 | 399.21B |
| October 29, 2026 | 390.42B |
| October 28, 2026 | 378.38B |
| October 27, 2026 | 378.38B |
| October 26, 2026 | 378.38B |
| October 23, 2026 | 392.65B |
| October 22, 2026 | 382.45B |
| October 21, 2026 | 382.45B |
| October 20, 2026 | 381.99B |
| October 19, 2026 | 365.29B |
| October 16, 2026 | 365.29B |
| October 15, 2026 | 365.29B |
| October 14, 2026 | 366.51B |
| Date | Value |
|---|---|
| October 13, 2026 | 352.39B |
| October 12, 2026 | 370.00B |
| October 09, 2026 | 352.94B |
| October 08, 2026 | 336.91B |
| October 07, 2026 | 347.19B |
| October 06, 2026 | 341.01B |
| October 05, 2026 | 334.58B |
| October 02, 2026 | 334.58B |
| October 01, 2026 | 338.63B |
| September 30, 2026 | 341.58B |
| September 29, 2026 | 339.62B |
| September 28, 2026 | 364.92B |
| September 25, 2026 | 346.39B |
| September 24, 2026 | 364.92B |
| September 23, 2026 | 366.71B |
| September 22, 2026 | 361.60B |
| September 21, 2026 | 354.53B |
| September 18, 2026 | 354.53B |
| September 17, 2026 | 356.97B |
| September 16, 2026 | 341.21B |
| September 15, 2026 | 345.80B |
| September 14, 2026 | 345.80B |
| September 11, 2026 | 345.00B |
| September 10, 2026 | 345.00B |
| September 09, 2026 | 358.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Novartis AG | 293.14B |
| Eli Lilly & Co. | 1.301T |
| Bristol Myers Squibb Co. | 121.76B |
| Merck & Co., Inc. | 341.60B |
| Pfizer Inc. | 159.94B |
Market Cap Related Metrics
| PE Ratio | 24.79 |
| PS Ratio | 5.024 |
| PEG Ratio | 0.8317 |
| Price to Free Cash Flow | 23.57 |
| Price | 479.42 |
| Earnings Yield | 4.03% |
| PEGY Ratio | 0.7588 |
| Operating PE Ratio | 16.38 |
| Normalized PE Ratio | 20.77 |